In this article , which appeared in the August 1, 2007, issue of Cancer Research (1), there are errors in the input lanes in Fig. 2A and vinculin lane in Fig. 2B, and duplication of the actin mRNA panel in Fig. 3A from the accompanying article by Bagheri-Yarmand and colleagues (2). The authors have replaced Figs. 2A, 2B, and 3A using data from repeat experiments. In addition, four duplicated MTA1 immunohistochemistry panels from the accompanying article by Bagheri-Yarmand and colleagues reused in Fig. 3D have been removed. There is no change in the legend or text for Fig. 2. In the text on page 7134, the last sentence in the first column should read, “Similarly, Pax5 immunohistochemistry of the human DLBCLs also showed strong nuclear Pax5 staining (+3 staining) in 52 of 76 (68.4%) cases (Fig. 3C).” These changes do not change the original scientific conclusions, and the validity of the findings remains the same.
The legend for Fig. 3 should read as follows:
Pax5 expression in MTA1-TG lymphomas. A, RT-PCR analysis of Pax5 expression in MTA1-TG lymphoma tumors. B, representative tumor samples isolated from spleen, gastrointestinal track (GI), and control tissue (spleen) were blotted with an anti-Pax5 antibody. C, expression of MTA1 in human DLBCL samples.
The corrected figures appear below. The authors regret these errors.
RSS Feeds